<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04906564</url>
  </required_header>
  <id_info>
    <org_study_id>KY 2017-141-01</org_study_id>
    <nct_id>NCT04906564</nct_id>
  </id_info>
  <brief_title>RNF213 Variants and Collateral Vessels in Moyamoya Disease</brief_title>
  <official_title>RNF213 Variants and Collateral Vessels in Moyamoya Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beijing Tiantan Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Beijing Tiantan Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to detect the association between RNF213 variants and collateral&#xD;
      vessels in patients with moyamoya disease.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Moyamoya disease (MMD) is a chronic cerebrovascular disorder characterized by the presence of&#xD;
      occlusion which occurs at the internal carotid arteries and their main branches during the&#xD;
      development of a basal collateral network. The ring finger 213 (RNF213) was identified as a&#xD;
      strong susceptibility gene in patients with MMD in East Asia. The role of RNF213 variants in&#xD;
      pathogenesis of MMD is still unclear. Specific &quot;moyamoya vessels&quot; correlate with the onset of&#xD;
      stroke. The purpose of this study is to investigate the relationship between RNF213 variants&#xD;
      and collateral vessels in patients with moyamoya disease, and provide potential pathogenesis&#xD;
      of moyamoya disease.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2019</start_date>
  <completion_date type="Anticipated">June 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Identification of RNF213 variants and different types of collateral vessels</measure>
    <time_frame>Baseline</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Identification of serum biomarkers and different types of collateral vessels</measure>
    <time_frame>Baseline</time_frame>
    <description>Hcy, HDL, LDL, ApoA, ApoB et al.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Identification of clinical characteristics and different types of collateral vessels</measure>
    <time_frame>Baseline</time_frame>
    <description>Age, Gender, Clinical manifestations, Comorbidities, BMI et al.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Identification of RNF213 variants, serum biomarkers, clinical characteristics and different types of postoperative collateral vessels</measure>
    <time_frame>6-12 months</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Moyamoya Disease</condition>
  <arm_group>
    <arm_group_label>Moyamoya disease patients</arm_group_label>
    <description>Moyamoya disease patients' inclusion Criteria:&#xD;
1. Written informed consent is obtained; 2. Patients with age between 4-60 years; 3. Cerebral digital subtraction contrast angiography (DSA) reveal severe stenosis or occlusion of the distal internal carotid or proximal middle and anterior cerebral arteries with prominent lenticulostriate 'moyamoya collaterals'.&#xD;
Exclusion Criteria:&#xD;
1. There are other vascular diseases, including systemic vasculitis, neurofibroma, meningitis, sickle cell disease, down's syndrome, and previous basilar radiotherapy; 2. Patients with cardiogenic embolism, including a history of atrial fibrillation, valvular disease or cardiac valve replacement; 3. Physical or subjective failure to cooperate with the examination or serious comorbid diseases.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Identification of genetic variants</intervention_name>
    <description>Identification of genetic variants</description>
    <arm_group_label>Moyamoya disease patients</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Whole blood&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Moyamoya disease patients&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Written informed consent is obtained&#xD;
&#xD;
          -  Patients with age between 4-60 years&#xD;
&#xD;
          -  Cerebral digital subtraction contrast angiography (DSA) reveal severe stenosis or&#xD;
             occlusion of the distal internal carotid or proximal middle and anterior cerebral&#xD;
             arteries with prominent lenticulostriate 'moyamoya collaterals'&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  There are other vascular diseases, including systemic vasculitis, neurofibroma,&#xD;
             meningitis, sickle cell disease, down's syndrome, and previous basilar radiotherapy&#xD;
&#xD;
          -  Patients with cardiogenic embolism, including a history of atrial fibrillation,&#xD;
             valvular disease or cardiac valve replacement&#xD;
&#xD;
          -  Physical or subjective failure to cooperate with the examination or serious comorbid&#xD;
             diseases&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>4 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Qian Zhang, MD</last_name>
    <phone>+8613611075005</phone>
    <email>zhangqianchina@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Chaofan Zeng, MD</last_name>
    <phone>+8613693276138</phone>
    <email>zchf723@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Beijing Tiantan Hospital Capital Medical University</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>May 25, 2021</study_first_submitted>
  <study_first_submitted_qc>May 25, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 28, 2021</study_first_posted>
  <last_update_submitted>May 30, 2021</last_update_submitted>
  <last_update_submitted_qc>May 30, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Moyamoya Disease</keyword>
  <keyword>RNF213 Variants</keyword>
  <keyword>Collateral Vessels</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Moyamoya Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

